Illumina and Pacific Biosciences terminate $1.2bn deal
03-01-2020
Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech
30-09-2019
Natee Meepian / iStockphoto.com
Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences (PacBio) for $1.2 billion.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Illumina, Pacific Biosciences, mergers and acquisitions, M&A, DNA sequencing, genomics, genetics
